Skip to content

Effect of a functional food supplementation on premenstrual water retention symptoms in women: a randomized, double-blind, placebo-controlled pilot study

Effect of a functional food ingredient on water retention symptoms in women with water retention symptoms in the luteal phase: a randomized, double-blind, placebo-controlled pilot study - Effect of a functional food supplementation on water retention symptoms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047989
Enrollment
40
Registered
2022-06-10
Start date
2014-06-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Oral intake of a functional food ingredient, twice a day for 7 to 15 days Oral intake of placebo, twice a day for 7 to 15 days

Sponsors

Medical Co. LTA Sugioka Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Premenopausal healthy women with normal menstrual cycle 2) Individuals who have cyclically onset or worsening of water retention symptoms during the luteal phase 3) Individuals who be able to understand the procedures 4) Individuals who agree to participate in the study by signing the informed consent

Exclusion criteria

Exclusion criteria: 1) Individuals who are pregnant, breast-feeding or intending to become pregnant 2) Individuals who have or had a history of an acute or chronic severe condition 3) Individuals who have a clinically relevant finding on the physical examination or blood testing 4) Individuals who take any continuous medications or dietary supplements

Design outcomes

Primary

MeasureTime frame
VAS scores of premenstrual symptoms on day 6, 7 and 8 of supplementation

Countries

Japan

Contacts

Public ContactHiroshi Tsukikawa

Medical Co. LTA Sugioka Memorial Hospital Planning and Coordination Dept

hiroshi-tsukikawa@lta-med.com092-662-3608

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026